Patent · US Active

Treating an atypical protein kinase C enzyme abnormality

US9795584B2 · kind B2 · utility

0Cited by

3References

4Claims

0Family size

Assignee

University of South Florida · US

Inventors

Robert Farese · San Francisco, US
Mini Paliyath Sajan · Wesley Chapel, US

Key dates

Filing date	Jul 30, 2014
Grant date	Oct 24, 2017
Priority date	—
Expiry date	Jul 30, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compounds, compositions, pharmaceutical formulations, methods of treating and methods of using aPKC inhibitors for treating and/or preventing of aPKC abnormalities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.